BRIEF-Biomarin Pharmaceutical Q2 EPS USD 0.23
Reuters2026/08/06 20:04Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Aug 06 (Reuters) - Biomarin Pharmaceutical Q2 revenue USD 990 million vs. IBES estimate USD 926.9 million.
- Q2 adjusted EPS USD 1.2 vs. IBES estimate USD 0.69
- Q2 net income USD 45 million
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Radana Bhaskara Finance releases transcript of 2026 annual public expose live event
Reuters•2026/09/10 04:19
Austral Gold discusses shift from Casposo tolling deal to buying Challenger’s Hualilan ore
Reuters•2026/09/10 04:18
NexAI Digital Infrastruktur shareholders approve up to 285,732,512-share rights issue plan
Reuters•2026/09/10 04:15
AEP lifts 2026 operating EPS forecast to $6.25-$6.55
Reuters•2026/09/10 04:12
Crypto prices
More
Bitcoin
BTC
$78,362.81
-0.64%
Ethereum
ETH
$2,476.03
-0.86%
Tether USDt
USDT
$0.9997
-0.01%
BNB
BNB
$723.1
-3.76%
XRP
XRP
$1.39
-2.43%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$102.01
-1.63%
TRON
TRX
$0.3397
+0.32%
Hyperliquid
HYPE
$84.21
-1.44%
Zcash
ZEC
$1,248.14
+3.92%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now